Rabbit anti-CD66a/e Antibody DL90096A
Specifications
| 50µl / 100µl |
Background:
Rabbit polyclonal antibody to CD66a/e
Alternative names:
CEACAM1; BGP; BGP1; Carcinoembryonic antigen-related cell adhesion molecule 1; Biliary glycoprotein 1; BGP-1; CD66a; CEACAM5; CEA; Carcinoembryonic antigen-related cell adhesion molecule 5; Carcinoembryonic antigen; CEA; Meconium antigen 100; CD66e
Clonality:
Polyclonal
Species reactivity:
H
Host:
Rabbit
Immunogen:
KLH-conjugated synthetic peptide encompassing a sequence within the N-term region of human CD66a/e. The exact sequence is proprietary.
Purification method:
The antibody was purified by immunogen affinity chromatography.
Concentration:
1mg/mL
Buffer:
Liquid in 0.42% Potassium phosphate, 0.87% Sodium chloride, pH 7.3, 30% glycerol, and 0.01% sodium azide.
Applications:
WB
Recommended dilution:
WB (1/500 - 1/1000)
Storage:
Store at -20℃. Avoid repeated freeze / thaw cycles.
WB description:
Western blot analysis of CD66a/e expression in A549 (A) whole cell lysates.
IHC description:
N/A
IF/ICC description:
N/A
IP description:
N/A
FC description:
N/A
ChIP description:
N/A
More info:
Email: info@sobekbio.com
Orders:
Email: orders@sobekbio.com
Fine Biotech is an ISO9001:2008 Certified Company,offers a full line of quality research kits,which include ELISA Kits,related ELISA assistant reagents and more high quality antibodies, recombinant proteins. Fine Biotech technical support are delicated to providing with professional and friendly assistance for our customers. Strict and multiple quality control ensure that our products continue to successfully supply for the international market. Moreover, we strive to continuously improve the customer experience through comprehensive technical support. High quality,rapid turnaround and personal support for all FineTest services are guaranteed. Should you have any problems,or any ideas on ways that we can improve our service,please feel free to call upon us.Thank you for your interest in FineTest products and we look forward to supplying you in the near future.